Gastrointestinal Bleeding in COVID-19 Infected Patients, and Management Outcomes.

Amnah Al HanaeiFatima AlKindiAysha Alkhemeiri Satish Chandrasekhar Nair

Published in: International journal of general medicine (2024)

The prevalence of GI bleeding observed in our cohort was approximately 0.45%, significantly lower than the global prevalence observed, majority (66%) had upper GI bleeding. The exact reasons for the observed low prevalence of GI bleeding cannot be explained and will be the subject of future research.

Keyphrases

risk factors
atrial fibrillation
coronavirus disease
sars cov
type diabetes
current status
insulin resistance
molecular dynamics